Hyderabad’s Gland Pharma to make 252 million doses of Sputnik V

Hyderabad’s Gland Pharma to make 252 million doses of Sputnik V Gland Pharma, which is based out of Hyderabad, has entered into an agreement with Russian sovereign wealth fund, Russian Direct Investment Fund (RDIF), to manufacture and supply 252 million (25.2 crore) doses of Russian Covid-19 vaccine Sputnik V. https://ift.tt/eA8V8J